InvestorService: Genmab, to Present at 2007 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

February 05, 2007 02:13 ET | Source: Genmab A/S Genmab A/S

Genmab's CEO will present at the 2007 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City on February 7.

Attachments

102611.pdf...

Recommended Reading

August 11, 2026 13:53 ET | Source: Genmab A/S

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement COPENHAGEN, Denmark; August 11, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 24,592 shares as a consequence of the exercise of employee warrants. The...
Read More
August 06, 2026 11:02 ET | Source: Genmab A/S

Genmab Announces Financial Results for the First Half of 2026

August 6, 2026 Copenhagen, Denmark; Interim Report for the Six Months Ended June 30, 2026 Highlights Genmab announced positive Phase 3 results for epcoritamab plus lenalidomide in patients with...
Read More